Latest Market News

BKI Investment Company Limited reported a solid half-year performance for December 2024, maintaining stable revenue and lifting its fully franked dividend by 1%. The company also introduced a neutralised Dividend Reinvestment Plan to better align shareholder interests and capital structure.

BKI Investment Company Limited reported a modest rise in ordinary revenue and declared a 1% higher interim dividend despite a challenging economic backdrop and softer special investment income.

BKI Investment Company Limited has announced a fully franked ordinary dividend of AUD 0.039 per share for the half-year ending December 31, 2024, payable on February 28, 2025. The company’s Dividend Reinvestment Plan remains active, offering shareholders flexibility.

BKI Investment Company Limited posted a decline in net profit and earnings per share for the half-year ending December 31, 2024, yet declared a higher fully franked interim dividend, signaling confidence amid economic headwinds.

Centrex Limited has initiated a $10.4 million Entitlement Offer to fund the critical Stage 1.5 Expansion of its Ardmore Phosphate Project, aiming to boost production capacity to 625ktpa. The company highlights the pivotal role of this capital raise in securing operational continuity amid notable financial and logistical risks.

Murray Cod Australia Limited has announced a 10-for-1 security consolidation affecting all ordinary shares and options, aiming to simplify its capital structure ahead of resumed trading in February 2025.

Charter Hall Wholesale Management Limited has secured majority control of Hotel Property Investments (HPI) with a 63.7% voting stake and the HPI board now recommends acceptance of the all-cash takeover offer valued at $3.752 per security.

Traffic Technologies Limited has landed a significant $3 million contract to supply smart LED streetlights to the City of Sydney, with potential extensions pushing the deal’s value to $5 million over nine years.

Energy Transition Minerals Ltd has successfully raised A$9.35 million through a strategic share placement, bolstering its financial position to advance the Kvanefjeld Rare Earths Project in Greenland and attracting new international institutional investors.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Stavely Minerals is progressing exploration at its Western Victoria copper-gold project, initiating a ground IP survey at the S41 gold prospect and confirming high-grade copper-silver mineralisation at the Junction discovery through recent drilling.

Carnarvon Energy and its partners have deferred key milestones in the Dorado Phase 1 liquids development, pushing back the Final Investment Decision and FPSO purchase. Despite the delay, the Joint Venture remains confident and plans further exploration drilling in 2026.